Factors associated with the development of reflux esophagitis after Helicobacter pylori eradication

Digestive Diseases and Sciences

Volumn 51, Issue 3, 2006, Pages 539-542

  Tsukada, Katsuhiko ^a   Katoh, Hiroyuki ^a   Miyazaki, Tatsuya ^a   Fukuchi, Minoru ^a   Kuwano, Hiroyuki ^a   Kimura, Hitoshi ^a   Fukai, Yasuyuki ^a   Inose, Takanori ^a   Motojima, Teiji ^b   Toda, Naotaka ^b   Yamada, Shuji ^b  

^a GUNMA UNIVERSITY   (Japan)

^b Motojima General Hospital   (Japan)

Author keywords

Eradication; Helicobacter pylori; Hiatal hernia; Reflux esophagitis

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE;

ADULT; ARTICLE; CONTROLLED STUDY; DUODENUM ULCER; ERADICATION THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL ENDOSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HIATUS HERNIA; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTPATIENT; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT DISEASE; REFLUX ESOPHAGITIS; TREATMENT FAILURE; UNIVARIATE ANALYSIS;

ADULT; AGE DISTRIBUTION; ANALYSIS OF VARIANCE; ANTI-BACTERIAL AGENTS; COHORT STUDIES; DRUG THERAPY, COMBINATION; ESOPHAGITIS, PEPTIC; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; STOMACH ULCER; TIME FACTORS;

EID: 33645849535     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-3167-2     Document Type: Article

References (23)

1. Marshall BJ, Warren JR: Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1:1311-1315, 1984
2. Correa P, Fox J, Fontham E, et al.: Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 66:2569-2574, 1990
3. Uemura N, Okamoto S, Yamamoto S, et al.: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345:784-789, 2001
4. Miwa H, Sugiyama Y, Ohkusa T, et al.: Improvement of reflux symptoms 3 years after cure of Helicobacter pylori infection: a case-controlled study in the Japanese population. Helicobacter 7:219-224, 2002
5. Koike T, Ohara S, Sekine H, et al.: Increased gastric acid secretion after Helicobacter pylori eradication may be a factor for developing reflux oesophagitis. Aliment Pharmacol Ther 15:813-820, 2001
6. Labenz J, Blum AL, Bayerdorffer E, Meining A, Stolte M, Borsch G: Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442-1447, 1997
7. Hamada H, Haruma K, Mihara M, et al.: High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 14:729-735, 2000
8. Wu JC, Chan FK, Wong SK, Lee YT, Leung WK, Sung JJ: Effect of Helicobacter pylori eradication on oesophageal acid exposure in patients with reflux oesophagitis. Aliment Pharmacol Ther 16:545-552, 2002
9. Kupcinskas L, Jonaitis L, Kiudelis G: A 1 year follow-up study of the consequences of Helicobacter pylori eradication in duodenal ulcer patients: unchanged frequency of erosive oesophagitis and decreased prevalence of non-erosive gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol 16:369-374, 2004
10. Ishiki K, Mizuno M, Take S, et al.: Helicobacter pylori eradication improves pre-existing reflux esophagitis in patients with duodenal ulcer disease. Clin Gastroenterol Hepatol 2:474-479, 2004
11. Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, et al: Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 53:12-20, 2004
12. Labenz J, Stolte M, Blum AL, et al.: Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 37:39-43, 1995
13. Malfertheiner P, Megraud F, O'Morain C, et al.: Current European concepts in the management of Helicobacter pylori infection - the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol 9:1-2, 1997
14. Befrits R, Sjostedt S, Odman B, Sorngard H, Lindberg G: 1. Curing Helicobacter pylori infection in patients with duodenal ulcer does not provoke gastroesophageal reflux disease. Helicobacter 5:202-205, 2000
15. Tsukada K, Miyazaki T, Katoh H, et al.: The incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori. Eur J Gastroenterol Hepatol 17:1025-1028, 2005
16. Lundell LR, Dent J, Bennett JR, et al.: Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 45:172-180, 1999
17. Labenz J, Jaspersen D, Kulig M, et al.: Risk factors for erosive esophagitis: a multivariate analysis based on the ProGERD study initiative. Am J Gastroenterol 99:1652-1656, 2004
18. Janssen MJ, Laheij RJ, Jansen JB, Boer WA: The influence of pre-treatment on cure rates of Helicobacter pylori eradication. Neth J Med 62:192-196, 2004
19. Gumurdulu Y, Serin E, Ozer B, et al.: Low eradication rate of Helicobacter pylori with triple 7-14 days and quadruple therapy in Turkey. World J Gastroenterol 10:668-671, 2004
20. Matsuo K, Hamajima N, Ikehara Y, et al.: Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin. Epidemiol Infect 130:227-233, 2003
21. Maeda S, Yoshida H, Ikenoue T, et al.: Structure of cag pathogenicity island in Japanese Helicobacter pylori isolates. Gut 44:336-341, 1999
22. Ikenoue T, Maeda S, Ogura K, et al.: Determination of Helicobacter pylori virulence by simple gene analysis of the cag pathogenicity island. Clin Diagn Lab Immunol 8:181-186, 2001
23. Maeda S, Ogura K, Yoshida H, et al.: Major virulence factors, VacA and CagA, are commonly positive in Helicobacter pylori isolates in Japan. Gut 42:338-343, 1998